Back
BioVie Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Sell
14
BIVI
BioVie
Last Price:
$1.05
Seasonality Move:
6.02%
Buy
75
CPRX
Catalyst Pharmaceuticals
Last Price:
$20.95
Seasonality Move:
10.33%
Buy
75
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals [CPRX] share price is $21.20. The Score for CPRX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIVI Stock Price Chart
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.
BIVI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 24 | Sell |
Chaikin Money Flow: | 42717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.83) | Sell |
Bollinger Bands (100): | (1.58 - 2.88) | Sell |
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 43.89 | Sell |
Chaikin Money Flow: | 222623 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.47 - 23.07) | Sell |
Bollinger Bands (100): | (21.13 - 22.81) | Sell |
BIVI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.17 | Sell |
20-day SMA: | 1.46 | Sell |
50-day SMA: | 1.8 | Sell |
200-day SMA: | 2.81 | Sell |
8-day EMA: | 1.18 | Sell |
20-day EMA: | 1.4 | Sell |
50-day EMA: | 1.74 | Sell |
200-day EMA: | 4.73 | Sell |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.87 | Sell |
20-day SMA: | 22.09 | Sell |
50-day SMA: | 22.2 | Sell |
200-day SMA: | 19.92 | Buy |
8-day EMA: | 21.61 | Sell |
20-day EMA: | 21.96 | Sell |
50-day EMA: | 22.07 | Sell |
200-day EMA: | 20.2 | Buy |
BioVie Earnings Growth & BIVI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.39 per share, and a decrease next year of $0.00 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.08 per share, and an increase next year of $0.24 per share.
BioVie Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Catalyst Pharmaceuticals Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |